Congenital and Maternal Point of Care Rapid Testing for Syphilis Study, Uganda
COMPARTS
1 other identifier
observational
24
1 country
1
Brief Summary
Syphilis is an infection which affects about 1 in 25 pregnant women in Uganda. If the infection is not diagnosed and treated this can be a risk to the mother and unborn baby's health. This study aims to see whether a new test for syphilis infection in mothers and babies which can give a result in 10 minutes is as good as the standard tests that are done in the laboratory and take hours or days to provide results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 8, 2025
CompletedFirst Posted
Study publicly available on registry
September 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedSeptember 15, 2025
September 1, 2025
3 months
September 8, 2025
September 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcomes
Correlation of binary non-treponemal IgM and IgG results for the Chembio DPP Syphilis TnT with RPR positivity. Correlation of binary treponemal IgM and IgG results for the Chembio DPP Syphilis TnT with Treponemal Antibody (TPAB) positivity. Correlation of binary IgA and IgM results for the Chembio DPP Syphilis CS and Chembio DPP Syphilis TnT to the RPR results in mother and baby to confirm the diagnosis of congenital syphilis in the neonate.
At enrolment
Eligibility Criteria
Mothers delivering at Kawempe National Referral Hospital with a positive syphilis rapid diagnostic test during their current pregnancy.
You may qualify if:
- Mothers delivering at Kawempe National Referral Hospital with a positive syphilis rapid diagnostic test during their current pregnancy.
You may not qualify if:
- Mothers who are unable to give written informed consent.
- Mothers with evidence of neurological symptoms compatible with neurological syphilis.
- Mothers who are aged less than 14 years. Emancipated and mature minors are allowed to consent for research per Ugandan law.11
- Mothers, who in the view of the study team, are unable to adhere to required study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St George's, University of Londonlead
- Johns Hopkins Universitycollaborator
- MU-JHU CAREcollaborator
Study Sites (1)
Kawempe National Referral Hospital
Kampala, Uganda
Biospecimen
Serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2025
First Posted
September 15, 2025
Study Start
September 1, 2025
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
September 15, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share